Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

August 1, 2022

Study Completion Date

September 20, 2022

Conditions

Hearing Loss, Sensorineural

Interventions

DRUG

Intracochlear Dexamethasone

intracochlear injection of dexamethasone with cochlear implantation

DRUG

Intratympanic Dexamethasone

intratympanic injection of dexamethasone with cochlear implantation

DRUG

No additional drugs(control Group)

Control group: No drugs will be injected middle ear with cochlear implantation

Trial Locations (1)

Pamukkale University, Denizli

All Listed Sponsors

lead

Pamukkale University

OTHER

NCT04397354 - Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells | Biotech Hunter | Biotech Hunter